News & Veröffentlichungen
| Aktuelles: |
|---|
| Neue Publikationen sind jetzt online:
Boss K et al. (2024) Binding and detoxification efficiency of albumin decline after haemodialysis. Nephrol Dial Transplant. Klinkmann G et al. (2023) Exploring Albumin Functionality Assays: A Pilot Study on Sepsis Evaluation in Intensive Care Medicine. Int J Mol Sci. Paar M et al. (2023) Determination of binding characteristics as a measure for effective albumin using different methods. Biochim Biophys Acta Gen Subj. Agarwal B et al. (2023) Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on-chronic liver failure. J Hepatol
|
| Treffen Sie uns auf folgender Veranstaltung: |
|---|
| Laufende Studien: |
|---|
| Kurztitel: AFORCE-1 – Albumin FunctiOn in eaRly CancEr (DRKS00025249) Partner: MEDIACC GmbH Studienzentren: Kliniken in Berlin– |
| Aktuelles: |
|---|
| Neue Publikationen sind jetzt online:
Boss K et al. (2024) Binding and detoxification efficiency of albumin decline after haemodialysis. Nephrol Dial Transplant. Klinkmann G et al. (2023) Exploring Albumin Functionality Assays: A Pilot Study on Sepsis Evaluation in Intensive Care Medicine. Int J Mol Sci. Paar M et al. (2023) Determination of binding characteristics as a measure for effective albumin using different methods. Biochim Biophys Acta Gen Subj. Agarwal B et al. (2023) Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on-chronic liver failure. J Hepatol |
| Treffen Sie uns auf folgender Veranstaltung: |
|---|
| Laufende Studien: |
|---|
| Kurztitel: AFORCE-1 – Albumin FunctiOn in eaRly CancEr (DRKS00025249) Partner: MEDIACC GmbH Studienzentren: Kliniken in Berlin– |